Targeting TAMs & CAFs in melanoma: New approaches to tumor microenvironment therapy
Oncology Research · 2025 · 33 (9) · 2221-2242
DOI: 10.32604/or.2025.064677 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2025. Verfasst von Yuriy Mayasin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Melanoma, Tumor-Associated Macrophages, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russia.
- Division of Medical and Biological Sciences, Tatarstan Academy of Sciences, Kazan, 420111, Russia.
Zitieren
APA
Mayasin, Y., Osinnikova, M., Osadchaya, D., Dmitrienko, V., Gorodilova, A., Kharisova, C., Kitaeva, K., Filin, I., Solovyeva, V., & Rizvanov, A. (2025). Targeting TAMs & CAFs in melanoma: New approaches to tumor microenvironment therapy. Oncology Research, 33(9), 2221-2242. https://doi.org/10.32604/or.2025.064677
Vancouver
Mayasin Y, Osinnikova M, Osadchaya D, Dmitrienko V, Gorodilova A, Kharisova C, et al. Targeting TAMs & CAFs in melanoma: New approaches to tumor microenvironment therapy. Oncology Research. 2025;33(9):2221-2242. doi:10.32604/or.2025.064677
BibTeX
@article{Mayasin2025,
author = {Mayasin, Yuriy and Osinnikova, Maria and Osadchaya, Daria and Dmitrienko, Victoria and Gorodilova, Anna and Kharisova, Chulpan and Kitaeva, Kristina and Filin, Ivan and Solovyeva, Valeria and Rizvanov, Albert},
title = {Targeting TAMs & CAFs in melanoma: New approaches to tumor microenvironment therapy},
journal = {Oncology Research},
year = {2025},
volume = {33},
number = {9},
pages = {2221--2242},
doi = {10.32604/or.2025.064677}
}
EUVIMED